Cargando…
Should we reconsider the routine use of placebo controls in clinical research?
BACKGROUND: Modern clinical-research practice favors placebo controls over usual-care controls whenever a credible placebo exists. An unrecognized consequence of this preference is that clinicians are more limited in their ability to provide the benefits of the non-specific healing effects of placeb...
Autores principales: | Avins, Andrew L, Cherkin, Daniel C, Sherman, Karen J, Goldberg, Harley, Pressman, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404895/ https://www.ncbi.nlm.nih.gov/pubmed/22540350 http://dx.doi.org/10.1186/1745-6215-13-44 |
Ejemplares similares
-
Initial experience with a group presentation of study results to research participants
por: Avins, Andrew L, et al.
Publicado: (2008) -
Should we reconsider how to assess eutrophication?
por: Polimene, L, et al.
Publicado: (2023) -
Diets for patients with chronic kidney disease, should we reconsider?
por: Mitch, William E., et al.
Publicado: (2016) -
Zoonosis–Why we should reconsider “What's in a name?”
por: Singh, Balbir B., et al.
Publicado: (2023) -
Should we reconsider high-risk features in thyroid ultrasonography?
por: Canpolat, Asena Gökçay, et al.
Publicado: (2023)